TerraTox - HIV-1 structure file, May 2004. Copyright ... - TerraBase Inc.

4353 C32H39N3O5 HIV-1 protease inhibitor; T-4842-016
4354 C32H39N5O7 AHPBA analogue; T-4457-072
4355 C32H39N7O6 AHPBA analogue; T-4457-075
3-amino-2-hydroxy-4-phenylbutanoic acid deriv.; T-
4356 C32H39N7O6 4441-002
Net-CO-(CH2)2-CO-Net; Net= neotropsinde(guanidylacetyl)
4357 C32H40N14O6
4358 C32H40N6O6 AHPBA analogue; T-4457-076
4359 C32H41NO3 oteromycin
4360 C32H41N3O9 AHPBA analogue; T-4457-055
4361 C32H41N5O5S A-155564
4362 C32H42N4O8 AHPBA analogue; T-4457-054
CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@](Cc4ccncc4)([H])C(=O)N[C@@
H]2[C@H](O)[C@H]([H])c3ccccc23
c1c(cccc2)c2nc1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N
2CCC[C@H]2C(=O)OC(C)(C)C
c1nc(cccc2)c2nc1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)
N2CCC[C@H]2C(=O)NC(C)(C)C
n1c2ccccc2ncc1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N
3CCC[C@H]3C(=O)NC(C)(C)C
O=C(Nc1cn(C)c(c1)C(=O)Nc2cnc(c2)C(=O)NCCC(N)=N)CCC(=O)Nc1cn(C)c(c1)C(=O)Nc2c
nc(c2)C(=O)NCCC(N)=N
c1c(cccc2)c2nc1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N
2CCC[C@H]2C(=O)NC(C)(C)C
C1[C@H](C)CC[C@@]2([H])[C@H](C(=O)C3=CC(O)(Cc4ccccc4)NC3=O)[C@H](\C(C)=C\C
(C)=C\C)C(C)=C[C@]12C 170591-45-4
c1ccccc1COC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N2C
CC[C@H]2C(=O)OC(C)(C)C
C1CCNC(=O)N1[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc3ccccc
3)NC(=O)OCc4scnc4
c1ccccc1COC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N2C
CC[C@H]2C(=O)OC(C)(C)C
4363 C32H43N3O2 5-oxopyrrolidine-3-carboxamide deriv.; T-4823-402 C1N(C5CCCCC5)C(=O)CC1C(=O)N(c2ccccc2)CCCN3CCC(CC3)Cc4ccccc4
4364 C32H43N5O7 tripeptide deriv.; T-4349-135
c1ccccc1COC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3CC
C[C@H]3C(=O)NC(C)(C)CC
4365 C32H43N5O7 tripeptide deriv.; T-4349-132
c1ccccc1COC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3CC
C[C@H]3C(=O)NCC(C)(C)C
4366 C32H43N5O7 tripeptide deriv.; T-4349-136
c1ccccc1COC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3CC
CC[C@H]3C(=O)NC(C)(C)C
4367 C32H43N5O7S KNI-162
c1ccccc1COC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3CS
C(C)(C)[C@H]3C(=O)NC(C)(C)C
4368 C32H44Br2N4O8 HIV-1 protease inhibitor; T-4067-042
c1cc(Br)ccc1CO[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NC)[C@H](O)[C@@H](O)[C@@H
](OCc2ccc(Br)cc2)C(=O)N[C@@H](C(C)C)C(=O)NC
4369 C32H44F3N5O7 hydroxyethylhydrazine deriv.; T-4391-709
COC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(C(F)(F)F)
cc2)NC(=O)[C@@H](C(C)C)NC(=O)OC
4370 C32H44N2O10 L-mannaric acid diamide deriv.; T-4515-023
COC(=O)[C@H](C(C)C)NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc2c
cccc2)C4(=O).COC(=O)[C@H](C(C)C)N4
4371 C32H44N2O10 L-mannaric acid diamide deriv.; T-4515-026
OC(=O)[C@H](CC(C)C)NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc2c
cccc2)C4(=O).OC(=O)[C@H](CC(C)C)N4
4372 C32H44N4O8 meta-/paracyclophane deriv.; T-4410-021
C5OCC[C@@H]5OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc2ccc(O3)cc2)C(
=O)N[C@@H](C(C)C)C(=O)NCCOCC3
COC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(C#N)cc2)
4373 C32H44N6O7 hydroxyethylhydrazine deriv.; T-4391-706
NC(=O)[C@@H](C(C)C)NC(=O)OC